| Literature DB >> 28471097 |
Steven E Kirberger1, Sofia D Maltseva1, Joseph C Manulik1, Samuel A Einstein2, Bradley P Weegman2, Michael Garwood2, William C K Pomerantz1.
Abstract
19 F MRI is valuable for in vivo imaging due to the only trace amounts of fluorine in biological systems. Because of the low sensitivity of MRI however, designing new fluorochemicals remains a significant challenge for achieving sufficient 19 F signal. Here, we describe a new class of high-signal, water-soluble fluorochemicals as 19 F MRI imaging agents. A polyamide backbone is used for tuning the proteolytic stability to avoid retention within the body, which is a limitation of current state-of-the-art perfluorochemicals. We show that unstructured peptides containing alternating N-ϵ-trifluoroacetyllysine and lysine provide a degenerate 19 F NMR signal. 19 F MRI phantom images provide sufficient contrast at micromolar concentrations, showing promise for eventual clinical applications. Finally, the degenerate high signal characteristics were retained when conjugated to a large protein, indicating potential for in vivo targeting applications, including molecular imaging and cell tracking.Entities:
Keywords: 19F NMR spectroscopy; fluorination; magnetic resonance imaging; molecular imaging; peptides
Mesh:
Substances:
Year: 2017 PMID: 28471097 PMCID: PMC5493043 DOI: 10.1002/anie.201700426
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336